WeVote
Log In

Bill

Bill

S 6103

Requires the office of minority health and health disparities prevention to conduct a study on the health impacts of COVID-19 on transgender and non-binary racial and ethnic minorities in New York state

2025 Regular Session Introduced by Kevin Parker

Requires a NY study by the Office of Minority Health to examine COVID-19 impacts on transgender and non-binary racial/ethnic minorities, guiding equitable public health planning.

REFERRED TO HEALTH
0
WeVote Research Nonpartisan
Bill Summary · S 6103

Summary of Bill S 6103

Overview

Bill S 6103 requires the New York Office of Minority Health and Health Disparities Prevention to conduct a study examining the health impacts of COVID-19 on transgender and non-binary racial and ethnic minorities within New York state. The bill was introduced on March 5, 2025 and has been referred to the Health committee.

Purpose and Intent

  • Establish a formal study to understand how COVID-19 has affected the health of a specific intersectional population: transgender and non-binary individuals who are racial and ethnic minorities in New York.
  • The aim is to identify health disparities, inform public health planning, and support evidence-based approaches to address inequities related to COVID-19 outcomes in this group.

Key Provisions

  • Directs the Office of Minority Health and Health Disparities Prevention to conduct the study.
  • The bill’s summary does not detail additional requirements such as study methods, duration, data sources, or reporting requirements. Specifics on methodology, timeline, and deliverables are not provided in the available information.

Population and Scope

  • Target population: transgender and non-binary individuals who identify as racial and ethnic minorities residing in New York State.
  • Focus: health impacts associated with COVID-19, with an intersectional lens on gender identity and race/ethnicity.

Procedural and Timeline Aspects

  • Status: REFERRED TO HEALTH, indicating the bill has moved from introduction to committee consideration.
  • Introduced: March 5, 2025.
  • No explicit timeline, reporting, or effective-date provisions are included in the available summary.

Fiscal and Administrative Considerations

  • The provided information does not specify funding, staffing, or budgetary implications.
  • In typical practice, a study of this nature would involve some level of departmental resources; actual costs would depend on scope and deliverables defined during committee review.

Potential Impact and Implications

  • Policy and Public Health: Findings could inform state public health strategies, equity-focused interventions, and data-collection practices for LGBTQ+ and minority populations.
  • Data Gaps: May highlight gaps in health data for transgender and non-binary individuals within racial and ethnic minority groups, potentially guiding future research.
  • Stakeholders: Could affect state health agencies, LGBTQ+ advocacy groups, minority community organizations, and healthcare providers serving these populations.

Related Legislation

  • Related bills from prior sessions: S 9102, S 5928, S 7897. These may share themes or propose similar studies or health-equity initiatives.

How to Track

  • The bill’s progression will be updated as it moves through the Health committee and beyond. Current status indicates it is awaiting committee action.

If you’d like, I can add a brief comparison with the related bills (S 9102, S 5928, S 7897) to highlight similarities or differences once you provide their text or summaries.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.